INS and stage 5 chronic kidney disease: One study included only patients with end-stage renal disease,22 whereas it was a specific exclusion criterion for another study.28 Three studies focused on insulin-treated patients only,24, 29, 30 whereas the other studies either included all patients regardless of treatment or did not report on treatment.